Overview
Afshin Rashtian is a Radiation Oncologist in Newport Beach, California. Dr. Rashtian is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Intraductal Papilloma, Meningioma, and Gamma Knife Radiosurgery.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1605 Avocado Ave, Newport Beach, CA 92660
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Regents Of The University Of California
Tania Kaprealian is a Radiation Oncologist in Los Angeles, California. Dr. Kaprealian is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Meningioma, Schwannoma, Acoustic Neuroma, Radiation Induced Meningioma, and Thalamotomy.
City Of Hope Medical Foundation
Eric Radany is a Radiation Oncologist in San Bernardino, California. Dr. Radany is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Breast Cancer, and Angiosarcoma.
The Regents Of The University Of California
John Hegde is a Radiation Oncologist in Los Angeles, California. Dr. Hegde is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Radiation Induced Meningioma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Prostatectomy, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Rashtian isAdvanced. Learn about Breast Cancer.
- Familial Prostate CancerDr. Rashtian isAdvanced. Learn about Familial Prostate Cancer.
- Intraductal PapillomaDr. Rashtian isAdvanced. Learn about Intraductal Papilloma.
- Lung CancerDr. Rashtian isAdvanced. Learn about Lung Cancer.
- MeningiomaDr. Rashtian isAdvanced. Learn about Meningioma.
- Metastatic Brain TumorDr. Rashtian isAdvanced. Learn about Metastatic Brain Tumor.
- Experienced
- Acoustic NeuromaDr. Rashtian isExperienced. Learn about Acoustic Neuroma.
- Adenoid Cystic CarcinomaDr. Rashtian isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Rashtian isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Rashtian isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Rashtian isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Rashtian isExperienced. Learn about Angiosarcoma.